Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 1999, p. 424-427, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Carbapenem Activities against Pseudomonas
aeruginosa: Respective Contributions of OprD and Efflux
Systems
Thilo
Köhler,*
Mehri
Michea-Hamzehpour,
Simone F.
Epp, and
Jean-Claude
Pechere
Department of Genetics and Microbiology,
Centre Médical Universitaire, CH-1211 Geneva 4, Switzerland
Received 12 June 1998/Returned for modification 2 October
1998/Accepted 24 November 1998
While meropenem MICs were strongly influenced by the presence or
absence of the MexAB-OprM efflux pump in both OprD-proficient and
-deficient strain backgrounds, MICs of imipenem and of ER-35786 remained unchanged, demonstrating that meropenem is a substrate of
MexAB-OprM but not imipenem and ER-35786. In vitro, all three carbapenems selected loss of OprD as a first mechanism of resistance. However, in an OprD-deficient background, meropenem was able to select
MexAB-OprM overproducers as a secondary resistance mechanism, while
ER-35786 selected a mutant cross-resistant to sparfloxacin and cefpirome.
*
Corresponding author. Mailing address: Department of
Genetics and Microbiology, CMU, 9, av. de Champel, CH-1211 Geneva 4, Switzerland. Phone: 41-22-7025655. Fax: 41-22-7025702. E-mail: Thilo.Kohler{at}medecine.unige.ch.
Antimicrobial Agents and Chemotherapy, February 1999, p. 424-427, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lister, P. D., Wolter, D. J., Hanson, N. D.
(2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev.
22: 582-610
[Abstract]
[Full Text]
-
Wolter, D. J., Black, J. A., Lister, P. D., Hanson, N. D.
(2009). Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype. J Antimicrob Chemother
64: 294-300
[Abstract]
[Full Text]
-
Wolter, D. J., Khalaf, N., Robledo, I. E., Vazquez, G. J., Sante, M. I., Aquino, E. E., Goering, R. V., Hanson, N. D.
(2009). Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 {beta}-Lactamases. Antimicrob. Agents Chemother.
53: 1660-1664
[Abstract]
[Full Text]
-
Jacoby, G. A.
(2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev.
22: 161-182
[Abstract]
[Full Text]
-
Kvist, M., Hancock, V., Klemm, P.
(2008). Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation. Appl. Environ. Microbiol.
74: 7376-7382
[Abstract]
[Full Text]
-
Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K., Ike, Y.
(2008). Fluoroquinolone Enhances the Mutation Frequency for Meropenem-Selected Carbapenem Resistance in Pseudomonas aeruginosa, but Use of the High-Potency Drug Doripenem Inhibits Mutant Formation. Antimicrob. Agents Chemother.
52: 3795-3800
[Abstract]
[Full Text]
-
Marchiaro, P., Ballerini, V., Spalding, T., Cera, G., Mussi, M. A., Moran-Barrio, J., Vila, A. J., Viale, A. M., Limansky, A. S.
(2008). A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers. J Antimicrob Chemother
62: 336-344
[Abstract]
[Full Text]
-
Tseng, S.-P., Hsueh, P.-R., Tsai, J.-C., Teng, L.-J.
(2007). Tn6001, a Transposon-Like Element Containing the blaVIM-3-Harboring Integron In450. Antimicrob. Agents Chemother.
51: 4187-4190
[Abstract]
[Full Text]
-
Maniati, M., Ikonomidis, A., Mantzana, P., Daponte, A., Maniatis, A. N., Pournaras, S.
(2007). A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J Antimicrob Chemother
60: 132-135
[Abstract]
[Full Text]
-
Pournaras, S., Ikonomidis, A., Markogiannakis, A., Spanakis, N., Maniatis, A. N., Tsakris, A.
(2007). Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J Med Microbiol
56: 66-70
[Abstract]
[Full Text]
-
Rodloff, A. C., Goldstein, E. J. C., Torres, A.
(2006). Two decades of imipenem therapy. J Antimicrob Chemother
58: 916-929
[Abstract]
[Full Text]
-
Quale, J., Bratu, S., Gupta, J., Landman, D.
(2006). Interplay of Efflux System, ampC, and oprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical Isolates.. Antimicrob. Agents Chemother.
50: 1633-1641
[Abstract]
[Full Text]
-
Lister, P. D., Wolter, D. J., Wickman, P. A., Reisbig, M. D.
(2006). Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs. J Antimicrob Chemother
57: 999-1003
[Abstract]
[Full Text]
-
Tam, V. H., Schilling, A. N., Neshat, S., Poole, K., Melnick, D. A., Coyle, E. A.
(2005). Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
49: 4920-4927
[Abstract]
[Full Text]
-
Wolter, D. J., Hanson, N. D., Lister, P. D.
(2005). AmpC and OprD Are Not Involved in the Mechanism of Imipenem Hypersusceptibility among Pseudomonas aeruginosa Isolates Overexpressing the mexCD-oprJ Efflux Pump. Antimicrob. Agents Chemother.
49: 4763-4766
[Abstract]
[Full Text]
-
Marchiaro, P., Mussi, M. A., Ballerini, V., Pasteran, F., Viale, A. M., Vila, A. J., Limansky, A. S.
(2005). Sensitive EDTA-Based Microbiological Assays for Detection of Metallo-{beta}-Lactamases in Nonfermentative Gram-Negative Bacteria. J. Clin. Microbiol.
43: 5648-5652
[Abstract]
[Full Text]
-
Ueda, Y., Kanazawa, K., Eguchi, K., Takemoto, K., Eriguchi, Y., Sunagawa, M.
(2005). In Vitro and In Vivo Antibacterial Activities of SM-216601, a New Broad-Spectrum Parenteral Carbapenem. Antimicrob. Agents Chemother.
49: 4185-4196
[Abstract]
[Full Text]
-
Pournaras, S., Maniati, M., Spanakis, N., Ikonomidis, A., Tassios, P. T., Tsakris, A., Legakis, N. J., Maniatis, A. N.
(2005). Spread of efflux pump-overexpressing, non-metallo-{beta}-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J Antimicrob Chemother
56: 761-764
[Abstract]
[Full Text]
-
Pitout, J. D. D., Gregson, D. B., Poirel, L., McClure, J.-A., Le, P., Church, D. L.
(2005). Detection of Pseudomonas aeruginosa Producing Metallo-{beta}-Lactamases in a Large Centralized Laboratory. J. Clin. Microbiol.
43: 3129-3135
[Abstract]
[Full Text]
-
Sobel, M. L., Neshat, S., Poole, K.
(2005). Mutations in PA2491 (mexS) Promote MexT-Dependent mexEF-oprN Expression and Multidrug Resistance in a Clinical Strain of Pseudomonas aeruginosa. J. Bacteriol.
187: 1246-1253
[Abstract]
[Full Text]
-
Oliver, A., Levin, B. R., Juan, C., Baquero, F., Blazquez, J.
(2004). Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections. Antimicrob. Agents Chemother.
48: 4226-4233
[Abstract]
[Full Text]
-
Mushtaq, S., Ge, Y., Livermore, D. M.
(2004). Doripenem versus Pseudomonas aeruginosa In Vitro: Activity against Characterized Isolates, Mutants, and Transconjugants and Resistance Selection Potential. Antimicrob. Agents Chemother.
48: 3086-3092
[Abstract]
[Full Text]
-
Van Bambeke, F., Glupczynski, Y., Plesiat, P., Pechere, J. C., Tulkens, P. M.
(2003). Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother
51: 1055-1065
[Full Text]
-
Fernandez-Cuenca, F., Martinez-Martinez, L., Conejo, M{a} C., Ayala, J. A., Perea, E. J., Pascual, A.
(2003). Relationship between {beta}-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother
51: 565-574
[Abstract]
[Full Text]
-
Van Eldere, J.
(2003). Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother
51: 347-352
[Abstract]
[Full Text]
-
Epp, S. F., Köhler, T., Plésiat, P., Michéa-Hamzehpour, M., Frey, J., Pechère, J.-C.
(2001). C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to Meropenem. Antimicrob. Agents Chemother.
45: 1780-1787
[Abstract]
[Full Text]
-
Livermore, D. M.
(2001). Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother
47: 247-250
[Full Text]
-
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., Gotoh, N.
(2001). Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates. Antimicrob. Agents Chemother.
45: 480-484
[Abstract]
[Full Text]
-
Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., Lomovskaya, O.
(2000). Interplay between Efflux Pumps May Provide Either Additive or Multiplicative Effects on Drug Resistance. J. Bacteriol.
182: 3142-3150
[Abstract]
[Full Text]
-
Yang, Y., Testa, R. T., Bhachech, N., Rasmussen, B. A., Bush, K.
(1999). Biochemical Characterization of Novel Tetrahydrofuranyl 1beta -Methylcarbapenems: Stability to Hydrolysis by Renal Dehydropeptidases and Bacterial beta -Lactamases, Binding to Penicillin Binding Proteins, and Permeability Properties. Antimicrob. Agents Chemother.
43: 2904-2909
[Abstract]
[Full Text]
-
Aires, J. R., Köhler, T., Nikaido, H., Plésiat, P.
(1999). Involvement of an Active Efflux System in the Natural Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother.
43: 2624-2628
[Abstract]
[Full Text]
-
Köhler, T., Epp, S. F., Curty, L. K., Pechère, J.-C.
(1999). Characterization of MexT, the Regulator of the MexE-MexF-OprN Multidrug Efflux System of Pseudomonas aeruginosa. J. Bacteriol.
181: 6300-6305
[Abstract]
[Full Text]